Cuban hepatitis B vax cuts disease

According to news reports, Cuba has eliminated viral hepatitis in its population under 15 through use of a vaccine against hepatitis B developed in Havana. The country has not seen a case of the disease in under 15s in 23 years, according to Maria Fonte Reyes of the Health Ministry. All Cubans under 31 have been vaccinated with Heberbiovac HB, created at Cuba's Center of Genetic Engineering and Biotechnology, as a result of a campaign involving every newborn since 1992. People on dialysis, students and healthcare workers are also given the vaccine. Article

Suggested Articles

A Lancet Infectious Diseases study shows antibody response persists for two years or more after a single shot of Merck’s rVSV-ZEBOV vaccine.

The partnership aims to make the production of vaccines that use adenovirus as vectors more cost-effective and contamination-free.

GSK's Shingrix has nabbed a huge chunk of the U.S. shingles-shot market, just five months after it was approved by the FDA.